| Year |
Citation |
Score |
| 2024 |
Wong CJ, Friedman SD, Snider L, Bennett SR, Jones TI, Jones PL, Shaw DWW, Blemker SS, Riem L, DuCharme O, Lemmers RJFL, van der Maarel SM, Wang LH, Tawil R, Statland JM, ... Tapscott SJ, et al. Regional and bilateral MRI and gene signatures in facioscapulohumeral dystrophy: implications for clinical trial design and mechanisms of disease progression. Human Molecular Genetics. PMID 38268317 DOI: 10.1093/hmg/ddae007 |
0.392 |
|
| 2023 |
Zheng D, Wondergem A, Kloet S, Willemsen I, Balog J, Tapscott SJ, Mahfouz A, van den Heuvel A, van der Maarel SM. snRNA-seq analysis in multinucleated myogenic FSHD cells identifies heterogeneous FSHD transcriptome signatures associated with embryonic-like program activation and oxidative stress-induced apoptosis. Human Molecular Genetics. PMID 37934801 DOI: 10.1093/hmg/ddad186 |
0.326 |
|
| 2023 |
Hamm DC, Paatela EM, Bennett SR, Wong CJ, Campbell AE, Wladyka CL, Smith AA, Jagannathan S, Hsieh AC, Tapscott SJ. The transcription factor DUX4 orchestrates translational reprogramming by broadly suppressing translation efficiency and promoting expression of DUX4-induced mRNAs. Plos Biology. 21: e3002317. PMID 37747887 DOI: 10.1371/journal.pbio.3002317 |
0.598 |
|
| 2023 |
Smith AA, Nip Y, Bennett SR, Hamm DC, Lemmers RJLF, van der Vliet PJ, Setty M, van der Maarel SM, Tapscott SJ. DUX4 expression in cancer induces a metastable early embryonic totipotent program. Cell Reports. 42: 113114. PMID 37691147 DOI: 10.1016/j.celrep.2023.113114 |
0.353 |
|
| 2023 |
Šikrová D, Testa AM, Willemsen I, van den Heuvel A, Tapscott SJ, Daxinger L, Balog J, van der Maarel SM. SMCHD1 and LRIF1 converge at the FSHD-associated D4Z4 repeat and LRIF1 promoter yet display different modes of action. Communications Biology. 6: 677. PMID 37380887 DOI: 10.1038/s42003-023-05053-0 |
0.336 |
|
| 2023 |
Spens AE, Sutliff NA, Bennett SR, Campbell AE, Tapscott SJ. Human DUX4 and mouse Dux interact with STAT1 and broadly inhibit interferon-stimulated gene induction. Elife. 12. PMID 37092726 DOI: 10.7554/eLife.82057 |
0.732 |
|
| 2023 |
Wong CJ, Friedman SD, Snider L, Bennett SR, Jones TI, Jones PL, Shaw DWW, Blemker SS, Riem L, DuCharme O, Lemmers RJFL, van der Maarel SRM, Wang LH, Tawil R, Statland JM, ... Tapscott SJ, et al. Validation of the association between MRI and gene signatures in facioscapulohumeral dystrophy muscle: implications for clinical trial design. Biorxiv : the Preprint Server For Biology. PMID 36865168 DOI: 10.1101/2023.02.20.529303 |
0.369 |
|
| 2023 |
Nip Y, Bennett SR, Smith AA, Jones TI, Jones PL, Tapscott SJ. Human DUX4 and porcine DUXC activate similar early embryonic programs in pig muscle cells: implications for preclinical models of FSHD. Human Molecular Genetics. PMID 36728804 DOI: 10.1093/hmg/ddad021 |
0.445 |
|
| 2022 |
Crist SB, Nemkov T, Dumpit RF, Dai J, Tapscott SJ, True LD, Swarbrick A, Sullivan LB, Nelson PS, Hansen KC, Ghajar CM. Unchecked oxidative stress in skeletal muscle prevents outgrowth of disseminated tumour cells. Nature Cell Biology. PMID 35411081 DOI: 10.1038/s41556-022-00881-4 |
0.34 |
|
| 2021 |
Wong CJ, Whiddon JL, Langford AT, Belleville AE, Tapscott SJ. Canine DUXC: Implications for DUX4 retrotransposition and preclinical models of FSHD. Human Molecular Genetics. PMID 34888646 DOI: 10.1093/hmg/ddab352 |
0.423 |
|
| 2021 |
Goossens R, Tihaya MS, van den Heuvel A, Tabot-Ndip K, Willemsen IM, Tapscott SJ, González-Prieto R, Chang JG, Vertegaal ACO, Balog J, van der Maarel SM. A proteomics study identifying interactors of the FSHD2 gene product SMCHD1 reveals RUVBL1-dependent DUX4 repression. Scientific Reports. 11: 23642. PMID 34880314 DOI: 10.1038/s41598-021-03030-3 |
0.304 |
|
| 2021 |
Bouwman LF, den Hamer B, van den Heuvel A, Franken M, Jackson M, Dwyer CA, Tapscott SJ, Rigo F, van der Maarel SM, de Greef JC. Systemic delivery of a DUX4-targeting antisense oligonucleotide to treat facioscapulohumeral muscular dystrophy. Molecular Therapy. Nucleic Acids. 26: 813-827. PMID 34729250 DOI: 10.1016/j.omtn.2021.09.010 |
0.383 |
|
| 2020 |
Wurmser M, Chaverot N, Madani R, Sakai H, Negroni E, Demignon J, Saint-Pierre B, Mouly V, Amthor H, Tapscott S, Birchmeier C, Tajbakhsh S, Le Grand F, Sotiropoulos A, Maire P. SIX1 and SIX4 homeoproteins regulate PAX7+ progenitor cell properties during fetal epaxial myogenesis. Development (Cambridge, England). PMID 32591430 DOI: 10.1242/Dev.185975 |
0.509 |
|
| 2020 |
Wong CJ, Wang LH, Friedman SD, Shaw D, Campbell AE, Budech CB, Lewis LM, Lemmers RJFL, Statland JM, Maarel SM, Tawil RN, Tapscott SJ. Longitudinal measures of RNA expression and disease activity in FSHD muscle biopsies. Human Molecular Genetics. PMID 32083293 DOI: 10.1093/hmg/ddaa031 |
0.426 |
|
| 2019 |
Resnick R, Wong CJ, Hamm DC, Bennett SR, Skene PJ, Hake SB, Henikoff S, van der Maarel SM, Tapscott SJ. DUX4-Induced Histone Variants H3.X and H3.Y Mark DUX4 Target Genes for Expression. Cell Reports. 29: 1812-1820.e5. PMID 31722199 DOI: 10.1016/j.celrep.2019.10.025 |
0.326 |
|
| 2019 |
Shadle SC, Bennett SR, Wong CJ, Karreman NA, Campbell AE, van der Maarel SM, Bass BL, Tapscott SJ. DUX4-induced bidirectional HSATII satellite repeat transcripts form intranuclear double stranded RNA foci in human cell models of FSHD. Human Molecular Genetics. PMID 31630170 DOI: 10.1093/Hmg/Ddz242 |
0.621 |
|
| 2019 |
Mikheeva SA, Camp ND, Huang L, Jain A, Jung SY, Avci NG, Tokita M, Wolf-Yadlin A, Zhang J, Tapscott SJ, Rostomily RC, Mikheev AM. TWIST1 Heterodimerization with E12 Requires Coordinated Protein Phosphorylation to Regulate Periostin Expression. Cancers. 11. PMID 31540485 DOI: 10.3390/Cancers11091392 |
0.312 |
|
| 2019 |
Chew GL, Campbell AE, De Neef E, Sutliff NA, Shadle SC, Tapscott SJ, Bradley RK. DUX4 Suppresses MHC Class I to Promote Cancer Immune Evasion and Resistance to Checkpoint Blockade. Developmental Cell. PMID 31327741 DOI: 10.1016/J.Devcel.2019.06.011 |
0.595 |
|
| 2019 |
Oliva J, Galasinski S, Richey A, Campbell AE, Meyers MJ, Modi N, Zhong JW, Tawil R, Tapscott SJ, Sverdrup FM. Clinically advanced p38 inhibitors suppress DUX4 expression in cellular and animal models of facioscapulohumeral muscular dystrophy. The Journal of Pharmacology and Experimental Therapeutics. PMID 31189728 DOI: 10.1124/jpet.119.259663 |
0.346 |
|
| 2019 |
Jagannathan S, Ogata Y, Gafken PR, Tapscott SJ, Bradley RK. Quantitative proteomics reveals key roles for post-transcriptional gene regulation in the molecular pathology of FSHD. Elife. 8. PMID 30644821 DOI: 10.7554/Elife.41740 |
0.72 |
|
| 2018 |
Heuvel AVD, Mahfouz A, Kloet SL, Balog J, Engelen BGMV, Tawil R, Tapscott SJ, Maarel SMV. Single-cell RNA-sequencing in facioscapulohumeral muscular dystrophy disease etiology and development. Human Molecular Genetics. PMID 30445587 DOI: 10.1093/Hmg/Ddy400 |
0.423 |
|
| 2018 |
Wang LH, Friedman SD, Shaw D, Snider L, Wong CJ, Budech CB, Poliachik SL, Gove NE, Lewis LM, Campbell AE, Lemmers RJFL, Maarel SM, Tapscott SJ, Tawil RN. MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD. Human Molecular Genetics. PMID 30312408 DOI: 10.1093/Hmg/Ddy364 |
0.389 |
|
| 2018 |
Lim JW, Wong CJ, Yao Z, Tawil R, van der Maarel SM, Miller DG, Tapscott SJ, Filippova GN. Small noncoding RNAs in FSHD2 muscle cells reveal both DUX4- and SMCHD1-specific signatures. Human Molecular Genetics. PMID 29741619 DOI: 10.1093/hmg/ddy173 |
0.395 |
|
| 2018 |
Campbell AE, Belleville A, Resnick R, Shadle SC, Tapscott SJ. Facioscapulohumeral dystrophy: Activating an early embryonic transcriptional program in human skeletal muscle. Human Molecular Genetics. PMID 29718206 DOI: 10.1093/hmg/ddy162 |
0.38 |
|
| 2018 |
Campbell AE, Shadle SC, Jagannathan S, Lim JW, Resnick R, Tawil R, van der Maarel SM, Tapscott SJ. NuRD and CAF-1-mediated silencing of the D4Z4 array is modulated by DUX4-induced MBD3L proteins. Elife. 7. PMID 29533181 DOI: 10.7554/Elife.31023 |
0.674 |
|
| 2017 |
Campbell AE, Oliva J, Yates MP, Zhong JW, Shadle SC, Snider L, Singh N, Tai S, Hiramuki Y, Tawil R, van der Maarel SM, Tapscott SJ, Sverdrup FM. BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells. Skeletal Muscle. 7: 16. PMID 28870238 DOI: 10.1186/s13395-017-0134-x |
0.401 |
|
| 2017 |
Mason AG, Slieker RC, Balog J, Lemmers RJLF, Wong CJ, Yao Z, Lim JW, Filippova GN, Ne E, Tawil R, Heijmans BT, Tapscott SJ, van der Maarel SM. SMCHD1 regulates a limited set of gene clusters on autosomal chromosomes. Skeletal Muscle. 7: 12. PMID 28593035 DOI: 10.1186/s13395-017-0129-7 |
0.318 |
|
| 2017 |
Mason AG, Slieker RC, Balog J, Lemmers RJLF, Wong CJ, Yao Z, Lim JW, Filippova GN, Ne E, Tawil R, Heijmans BT, Tapscott SJ, van der Maarel SM. SMCHD1 regulates a limited set of gene clusters on autosomal chromosomes. Skeletal Muscle. 7: 12. PMID 28587678 DOI: 10.1186/s13395-017-0129-7 |
0.318 |
|
| 2017 |
Hendrickson PG, Doráis JA, Grow EJ, Whiddon JL, Lim JW, Wike CL, Weaver BD, Pflueger C, Emery BR, Wilcox AL, Nix DA, Peterson CM, Tapscott SJ, Carrell DT, Cairns BR. Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL/HERVL retrotransposons. Nature Genetics. PMID 28459457 DOI: 10.1097/Ogx.0000000000000471 |
0.337 |
|
| 2017 |
Whiddon JL, Langford AT, Wong CJ, Zhong JW, Tapscott SJ. Conservation and innovation in the DUX4-family gene network. Nature Genetics. PMID 28459454 DOI: 10.1038/ng.3846 |
0.405 |
|
| 2017 |
Shadle SC, Zhong JW, Campbell AE, Conerly ML, Jagannathan S, Wong CJ, Morello TD, van der Maarel SM, Tapscott SJ. DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy. Plos Genetics. 13: e1006658. PMID 28273136 DOI: 10.1371/Journal.Pgen.1006658 |
0.625 |
|
| 2016 |
Jagannathan S, Shadle SC, Resnick R, Snider L, Tawil RN, van der Maarel SM, Bradley RK, Tapscott SJ. Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells. Human Molecular Genetics. 25: 4419-4431. PMID 28171552 DOI: 10.1093/Hmg/Ddw271 |
0.741 |
|
| 2016 |
Jagannathan S, Shadle S, Resnick R, Snider L, Tawil RN, van der Maarel SM, Bradley RK, Tapscott SJ. Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells. Human Molecular Genetics. PMID 27530253 DOI: 10.1093/hmg/ddw271 |
0.741 |
|
| 2016 |
Balog J, Thijssen PE, Shadle S, Straasheijm KR, van der Vliet PJ, Krom YD, van den Boogaard ML, de Jong A, Lemmers RJ, Tawil R, Tapscott SJ, van der Maarel SM. Corrigendum. Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4. Epigenetics. 11: 175. PMID 27058812 DOI: 10.1080/15592294.2016.1161273 |
0.398 |
|
| 2016 |
Conerly ML, Yao Z, Zhong JW, Groudine M, Tapscott SJ. Distinct Activities of Myf5 and MyoD Indicate Separate Roles in Skeletal Muscle Lineage Specification and Differentiation. Developmental Cell. 36: 375-85. PMID 26906734 DOI: 10.1016/j.devcel.2016.01.021 |
0.437 |
|
| 2015 |
Balog J, Thijssen PE, Shadle S, Straasheijm KR, Van Der Vliet PJ, Krom YD, Van Den Boogaard ML, De Jong A, Lemmers RJ, Tawil R, Tapscott SJ, Van Der Maarel SM. Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4. Epigenetics. 0. PMID 26575099 DOI: 10.1080/15592294.2015.1113798 |
0.459 |
|
| 2015 |
Daxinger L, Tapscott SJ, van der Maarel SM. Genetic and epigenetic contributors to FSHD. Current Opinion in Genetics & Development. 33: 56-61. PMID 26356006 DOI: 10.1016/j.gde.2015.08.007 |
0.309 |
|
| 2015 |
Lim JW, Snider L, Yao Z, Tawil R, van der Maarel SM, Rigo F, Bennett CF, Filippova GN, Tapscott SJ. DICER/AGO-dependent Epigenetic Silencing of D4Z4 Repeats Enhanced by Exogenous siRNA Suggests Mechanisms and Therapies for FSHD. Human Molecular Genetics. PMID 26041815 DOI: 10.1093/hmg/ddv206 |
0.446 |
|
| 2015 |
Lemmers RJ, van den Boogaard ML, van der Vliet PJ, Donlin-Smith CM, Nations SP, Ruivenkamp CA, Heard P, Bakker B, Tapscott S, Cody JD, Tawil R, van der Maarel SM. Hemizygosity for SMCHD1 in Facioscapulohumeral Muscular Dystrophy Type 2: Consequences for 18p Deletion Syndrome. Human Mutation. 36: 679-83. PMID 25820463 DOI: 10.1002/Humu.22792 |
0.31 |
|
| 2015 |
Feng Q, Snider L, Jagannathan S, Tawil R, van der Maarel SM, Tapscott SJ, Bradley RK. A feedback loop between nonsense-mediated decay and the retrogene DUX4 in facioscapulohumeral muscular dystrophy. Elife. 4. PMID 25564732 DOI: 10.7554/Elife.04996 |
0.74 |
|
| 2015 |
Yang ZJ, Broz DK, Noderer WL, Ferreira JP, Overton KW, Spencer SL, Meyer T, Tapscott SJ, Attardi LD, Wang CL. p53 suppresses muscle differentiation at the myogenin step in response to genotoxic stress. Cell Death and Differentiation. 22: 560-73. PMID 25501595 DOI: 10.1038/Cdd.2014.189 |
0.357 |
|
| 2015 |
Halbert C, Goddard M, Lee D, Mack D, Butts T, Grange R, Johnson M, Storb R, Miller D, Chamberlain J, Tapscott S, Childers M, Wang Z. 398. Sustained Expression of a Canine Micro-Dystrophin Lead To Improvement of Limb Muscle Function in Dystrophic Dogs Following Large Scale AAV-Mediated Treatment Molecular Therapy. 23: S158. DOI: 10.1016/S1525-0016(16)34007-2 |
0.476 |
|
| 2014 |
Thijssen PE, Balog J, Yao Z, Pham TP, Tawil R, Tapscott SJ, Van der Maarel SM. DUX4 promotes transcription of FRG2 by directly activating its promoter in facioscapulohumeral muscular dystrophy. Skeletal Muscle. 4: 19. PMID 25789155 DOI: 10.1186/2044-5040-4-19 |
0.469 |
|
| 2014 |
Tawil R, van der Maarel SM, Tapscott SJ. Facioscapulohumeral dystrophy: the path to consensus on pathophysiology. Skeletal Muscle. 4: 12. PMID 24940479 DOI: 10.1186/2044-5040-4-12 |
0.368 |
|
| 2014 |
Yao Z, Snider L, Balog J, Lemmers RJ, Van Der Maarel SM, Tawil R, Tapscott SJ. DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle. Human Molecular Genetics. 23: 5342-52. PMID 24861551 DOI: 10.1093/hmg/ddu251 |
0.481 |
|
| 2013 |
Young JM, Whiddon JL, Yao Z, Kasinathan B, Snider L, Geng LN, Balog J, Tawil R, van der Maarel SM, Tapscott SJ. DUX4 binding to retroelements creates promoters that are active in FSHD muscle and testis. Plos Genetics. 9: e1003947. PMID 24278031 DOI: 10.1371/journal.pgen.1003947 |
0.427 |
|
| 2013 |
Yao Z, Farr GH, Tapscott SJ, Maves L. Pbx and Prdm1a transcription factors differentially regulate subsets of the fast skeletal muscle program in zebrafish. Biology Open. 2: 546-55. PMID 23789105 DOI: 10.1242/bio.20133921 |
0.483 |
|
| 2013 |
Fong AP, Tapscott SJ. Skeletal muscle programming and re-programming. Current Opinion in Genetics & Development. 23: 568-73. PMID 23756045 DOI: 10.1016/j.gde.2013.05.002 |
0.422 |
|
| 2013 |
Sebastian S, Faralli H, Yao Z, Rakopoulos P, Palii C, Cao Y, Singh K, Liu QC, Chu A, Aziz A, Brand M, Tapscott SJ, Dilworth FJ. Tissue-specific splicing of a ubiquitously expressed transcription factor is essential for muscle differentiation. Genes & Development. 27: 1247-59. PMID 23723416 DOI: 10.1101/gad.215400.113 |
0.511 |
|
| 2013 |
Parker MH, Tapscott SJ. Expanding donor muscle-derived cells for transplantation. Current Protocols in Stem Cell Biology. Unit 2C.4. PMID 23661246 DOI: 10.1002/9780470151808.sc02c04s25 |
0.365 |
|
| 2013 |
Krom YD, Thijssen PE, Young JM, den Hamer B, Balog J, Yao Z, Maves L, Snider L, Knopp P, Zammit PS, Rijkers T, van Engelen BG, Padberg GW, Frants RR, Tawil R, ... Tapscott SJ, et al. Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHD. Plos Genetics. 9: e1003415. PMID 23593020 DOI: 10.1371/journal.pgen.1003415 |
0.419 |
|
| 2013 |
Borensztein M, Monnier P, Court F, Louault Y, Ripoche MA, Tiret L, Yao Z, Tapscott SJ, Forné T, Montarras D, Dandolo L. Myod and H19-Igf2 locus interactions are required for diaphragm formation in the mouse. Development (Cambridge, England). 140: 1231-9. PMID 23406902 DOI: 10.1242/dev.084665 |
0.384 |
|
| 2013 |
MacQuarrie KL, Yao Z, Fong AP, Diede SJ, Rudzinski ER, Hawkins DS, Tapscott SJ. Comparison of genome-wide binding of MyoD in normal human myogenic cells and rhabdomyosarcomas identifies regional and local suppression of promyogenic transcription factors. Molecular and Cellular Biology. 33: 773-84. PMID 23230269 DOI: 10.1128/MCB.00916-12 |
0.426 |
|
| 2012 |
Krom YD, Dumonceaux J, Mamchaoui K, den Hamer B, Mariot V, Negroni E, Geng LN, Martin N, Tawil R, Tapscott SJ, van Engelen BG, Mouly V, Butler-Browne GS, van der Maarel SM. Generation of isogenic D4Z4 contracted and noncontracted immortal muscle cell clones from a mosaic patient: a cellular model for FSHD. The American Journal of Pathology. 181: 1387-401. PMID 22871573 DOI: 10.1016/j.ajpath.2012.07.007 |
0.353 |
|
| 2012 |
Parker MH, Loretz C, Tyler AE, Duddy WJ, Hall JK, Olwin BB, Bernstein ID, Storb R, Tapscott SJ. Activation of Notch signaling during ex vivo expansion maintains donor muscle cell engraftment. Stem Cells (Dayton, Ohio). 30: 2212-20. PMID 22865615 DOI: 10.1002/Stem.1181 |
0.382 |
|
| 2012 |
Wang Z, Storb R, Halbert CL, Banks GB, Butts TM, Finn EE, Allen JM, Miller AD, Chamberlain JS, Tapscott SJ. Successful regional delivery and long-term expression of a dystrophin gene in canine muscular dystrophy: a preclinical model for human therapies. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 1501-7. PMID 22692496 DOI: 10.1038/mt.2012.111 |
0.382 |
|
| 2012 |
Weber CM, Martindale MQ, Tapscott SJ, Unguez GA. Activation of Pax7-positive cells in a non-contractile tissue contributes to regeneration of myogenic tissues in the electric fish S. macrurus. Plos One. 7: e36819. PMID 22685526 DOI: 10.1371/Journal.Pone.0036819 |
0.346 |
|
| 2012 |
Macquarrie KL, Yao Z, Young JM, Cao Y, Tapscott SJ. miR-206 integrates multiple components of differentiation pathways to control the transition from growth to differentiation in rhabdomyosarcoma cells. Skeletal Muscle. 2: 7. PMID 22541669 DOI: 10.1186/2044-5040-2-7 |
0.34 |
|
| 2012 |
Parker MH, Loretz C, Tyler AE, Snider L, Storb R, Tapscott SJ. Inhibition of CD26/DPP-IV enhances donor muscle cell engraftment and stimulates sustained donor cell proliferation. Skeletal Muscle. 2: 4. PMID 22340947 DOI: 10.1186/2044-5040-2-4 |
0.343 |
|
| 2012 |
Geng LN, Yao Z, Snider L, Fong AP, Cech JN, Young JM, van der Maarel SM, Ruzzo WL, Gentleman RC, Tawil R, Tapscott SJ. DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Developmental Cell. 22: 38-51. PMID 22209328 DOI: 10.1016/J.Devcel.2011.11.013 |
0.396 |
|
| 2011 |
Conerly ML, MacQuarrie KL, Fong AP, Yao Z, Tapscott SJ. Polycomb-mediated repression during terminal differentiation: what don't you want to be when you grow up? Genes & Development. 25: 997-1003. PMID 21576260 DOI: 10.1101/gad.2054311 |
0.351 |
|
| 2011 |
Geng LN, Tyler AE, Tapscott SJ. Immunodetection of human double homeobox 4. Hybridoma (2005). 30: 125-30. PMID 21529284 DOI: 10.1089/hyb.2010.0094 |
0.372 |
|
| 2011 |
van der Maarel SM, Tawil R, Tapscott SJ. Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence. Trends in Molecular Medicine. 17: 252-8. PMID 21288772 DOI: 10.1016/j.molmed.2011.01.001 |
0.345 |
|
| 2011 |
Wang Z, Tapscott SJ, Storb R. Local gene delivery and methods to control immune responses in muscles of normal and dystrophic dogs. Methods in Molecular Biology (Clifton, N.J.). 709: 265-75. PMID 21194034 DOI: 10.1007/978-1-61737-982-6_17 |
0.331 |
|
| 2011 |
Palii CG, Perez-Iratxeta C, Yao Z, Cao Y, Dai F, Davison J, Atkins H, Allan D, Dilworth FJ, Gentleman R, Tapscott SJ, Brand M. Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages. The Embo Journal. 30: 494-509. PMID 21179004 DOI: 10.1038/emboj.2010.342 |
0.338 |
|
| 2011 |
Gianakopoulos PJ, Mehta V, Voronova A, Cao Y, Yao Z, Coutu J, Wang X, Waddington MS, Tapscott SJ, Skerjanc IS. MyoD directly up-regulates premyogenic mesoderm factors during induction of skeletal myogenesis in stem cells. The Journal of Biological Chemistry. 286: 2517-25. PMID 21078671 DOI: 10.1074/jbc.M110.163709 |
0.5 |
|
| 2010 |
Snider L, Geng LN, Lemmers RJ, Kyba M, Ware CB, Nelson AM, Tawil R, Filippova GN, van der Maarel SM, Tapscott SJ, Miller DG. Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. Plos Genetics. 6: e1001181. PMID 21060811 DOI: 10.1371/Journal.Pgen.1001181 |
0.489 |
|
| 2010 |
Lee KS, Cao Y, Witwicka HE, Tom S, Tapscott SJ, Wang EH. RNA-binding protein Muscleblind-like 3 (MBNL3) disrupts myocyte enhancer factor 2 (Mef2) {beta}-exon splicing. The Journal of Biological Chemistry. 285: 33779-87. PMID 20709755 DOI: 10.1074/Jbc.M110.124255 |
0.457 |
|
| 2010 |
Cao Y, Yao Z, Sarkar D, Lawrence M, Sanchez GJ, Parker MH, MacQuarrie KL, Davison J, Morgan MT, Ruzzo WL, Gentleman RC, Tapscott SJ. Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming. Developmental Cell. 18: 662-74. PMID 20412780 DOI: 10.1016/J.Devcel.2010.02.014 |
0.433 |
|
| 2009 |
Maves L, Tyler A, Moens CB, Tapscott SJ. Pbx acts with Hand2 in early myocardial differentiation. Developmental Biology. 333: 409-18. PMID 19607825 DOI: 10.1016/J.Ydbio.2009.07.004 |
0.418 |
|
| 2009 |
Yang Z, MacQuarrie KL, Analau E, Tyler AE, Dilworth FJ, Cao Y, Diede SJ, Tapscott SJ. MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state. Genes & Development. 23: 694-707. PMID 19299559 DOI: 10.1101/gad.1765109 |
0.436 |
|
| 2008 |
Kim HJ, Archer E, Escobedo N, Tapscott SJ, Unguez GA. Inhibition of mammalian muscle differentiation by regeneration blastema extract of Sternopygus macrurus. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 237: 2830-43. PMID 18816861 DOI: 10.1002/dvdy.21702 |
0.377 |
|
| 2008 |
Kimura E, Han JJ, Li S, Fall B, Ra J, Haraguchi M, Tapscott SJ, Chamberlain JS. Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy. Human Molecular Genetics. 17: 2507-17. PMID 18511457 DOI: 10.1093/hmg/ddn151 |
0.447 |
|
| 2007 |
Rampalli S, Li L, Mak E, Ge K, Brand M, Tapscott SJ, Dilworth FJ. p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation. Nature Structural & Molecular Biology. 14: 1150-6. PMID 18026121 DOI: 10.1038/Nsmb1316 |
0.429 |
|
| 2007 |
Maves L, Waskiewicz AJ, Paul B, Cao Y, Tyler A, Moens CB, Tapscott SJ. Pbx homeodomain proteins direct Myod activity to promote fast-muscle differentiation. Development (Cambridge, England). 134: 3371-82. PMID 17699609 DOI: 10.1242/Dev.003905 |
0.494 |
|
| 2007 |
Olguin HC, Yang Z, Tapscott SJ, Olwin BB. Reciprocal inhibition between Pax7 and muscle regulatory factors modulates myogenic cell fate determination. The Journal of Cell Biology. 177: 769-79. PMID 17548510 DOI: 10.1083/Jcb.200608122 |
0.446 |
|
| 2007 |
Wang Z, Kuhr CS, Allen JM, Blankinship M, Gregorevic P, Chamberlain JS, Tapscott SJ, Storb R. Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1160-6. PMID 17426713 DOI: 10.1038/Sj.Mt.6300161 |
0.32 |
|
| 2007 |
Wang Z, Allen JM, Riddell SR, Gregorevic P, Storb R, Tapscott SJ, Chamberlain JS, Kuhr CS. Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy. Human Gene Therapy. 18: 18-26. PMID 17176210 DOI: 10.1089/hum.2006.093 |
0.317 |
|
| 2006 |
Rosenberg MI, Georges SA, Asawachaicharn A, Analau E, Tapscott SJ. MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206. The Journal of Cell Biology. 175: 77-85. PMID 17030984 DOI: 10.1083/jcb.200603039 |
0.46 |
|
| 2006 |
Caretti G, Schiltz RL, Dilworth FJ, Di Padova M, Zhao P, Ogryzko V, Fuller-Pace FV, Hoffman EP, Tapscott SJ, Sartorelli V. The RNA helicases p68/p72 and the noncoding RNA SRA are coregulators of MyoD and skeletal muscle differentiation. Developmental Cell. 11: 547-60. PMID 17011493 DOI: 10.1016/j.devcel.2006.08.003 |
0.304 |
|
| 2006 |
Cao Y, Kumar RM, Penn BH, Berkes CA, Kooperberg C, Boyer LA, Young RA, Tapscott SJ. Global and gene-specific analyses show distinct roles for Myod and Myog at a common set of promoters. The Embo Journal. 25: 502-11. PMID 16437161 DOI: 10.1038/Sj.Emboj.7600958 |
0.421 |
|
| 2006 |
Unguez GA, Kim H, Tapscott S. Inhibition of mammalian muscle differentiation by blastema extract of S. macrurus Developmental Biology. 295: 354-355. DOI: 10.1016/J.Ydbio.2006.04.091 |
0.402 |
|
| 2005 |
Berkes CA, Tapscott SJ. MyoD and the transcriptional control of myogenesis. Seminars in Cell & Developmental Biology. 16: 585-95. PMID 16099183 DOI: 10.1016/j.semcdb.2005.07.006 |
0.466 |
|
| 2005 |
Tapscott SJ. The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development (Cambridge, England). 132: 2685-95. PMID 15930108 DOI: 10.1242/dev.01874 |
0.467 |
|
| 2005 |
Snider L, Tapscott SJ. XIC is required for Siamois activity and dorsoanterior development. Molecular and Cellular Biology. 25: 5061-72. PMID 15923623 DOI: 10.1128/MCB.25.12.5061-5072.2005 |
0.301 |
|
| 2005 |
Strand AD, Aragaki AK, Shaw D, Bird T, Holton J, Turner C, Tapscott SJ, Tabrizi SJ, Schapira AH, Kooperberg C, Olson JM. Gene expression in Huntington's disease skeletal muscle: a potential biomarker. Human Molecular Genetics. 14: 1863-76. PMID 15888475 DOI: 10.1093/Hmg/Ddi192 |
0.36 |
|
| 2005 |
de la Serna IL, Ohkawa Y, Berkes CA, Bergstrom DA, Dacwag CS, Tapscott SJ, Imbalzano AN. MyoD targets chromatin remodeling complexes to the myogenin locus prior to forming a stable DNA-bound complex. Molecular and Cellular Biology. 25: 3997-4009. PMID 15870273 DOI: 10.1128/Mcb.25.10.3997-4009.2005 |
0.4 |
|
| 2004 |
Penn BH, Bergstrom DA, Dilworth FJ, Bengal E, Tapscott SJ. A MyoD-generated feed-forward circuit temporally patterns gene expression during skeletal muscle differentiation. Genes & Development. 18: 2348-53. PMID 15466486 DOI: 10.1101/gad.1234304 |
0.434 |
|
| 2004 |
Dell'Agnola C, Wang Z, Storb R, Tapscott SJ, Kuhr CS, Hauschka SD, Lee RS, Sale GE, Zellmer E, Gisburne S, Bogan J, Kornegay JN, Cooper BJ, Gooley TA, Little MT. Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs. Blood. 104: 4311-8. PMID 15328150 DOI: 10.1182/Blood-2004-06-2247 |
0.301 |
|
| 2004 |
Dilworth FJ, Seaver KJ, Fishburn AL, Htet SL, Tapscott SJ. In vitro transcription system delineates the distinct roles of the coactivators pCAF and p300 during MyoD/E47-dependent transactivation Proceedings of the National Academy of Sciences of the United States of America. 101: 11593-11598. PMID 15289617 DOI: 10.1073/pnas.0404192101 |
0.321 |
|
| 2004 |
Berkes CA, Bergstrom DA, Penn BH, Seaver KJ, Knoepfler PS, Tapscott SJ. Pbx marks genes for activation by MyoD indicating a role for a homeodomain protein in establishing myogenic potential. Molecular Cell. 14: 465-77. PMID 15149596 DOI: 10.1016/S1097-2765(04)00260-6 |
0.463 |
|
| 2004 |
Lin CH, Stoeck J, Ravanpay AC, Guillemot F, Tapscott SJ, Olson JM. Regulation of neuroD2 expression in mouse brain. Developmental Biology. 265: 234-45. PMID 14697366 DOI: 10.1016/J.Ydbio.2003.08.027 |
0.307 |
|
| 2003 |
Winokur ST, Chen YW, Masny PS, Martin JH, Ehmsen JT, Tapscott SJ, van der Maarel SM, Hayashi Y, Flanigan KM. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Human Molecular Genetics. 12: 2895-907. PMID 14519683 DOI: 10.1093/Hmg/Ddg327 |
0.467 |
|
| 2003 |
Snider L, Tapscott SJ. Emerging parallels in the generation and regeneration of skeletal muscle Cell. 113: 811-812. PMID 12837235 DOI: 10.1016/S0092-8674(03)00474-4 |
0.345 |
|
| 2002 |
Luthi-Carter R, Hanson SA, Strand AD, Bergstrom DA, Chun W, Peters NL, Woods AM, Chan EY, Kooperberg C, Krainc D, Young AB, Tapscott SJ, Olson JM. Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain. Human Molecular Genetics. 11: 1911-26. PMID 12165554 DOI: 10.1093/Hmg/11.17.1911 |
0.344 |
|
| 2002 |
Sato S, Nakamura M, Cho DH, Tapscott SJ, Ozaki H, Kawakami K. Identification of transcriptional targets for Six5: Implication for the pathogenesis of myotonic dystrophy type 1 Human Molecular Genetics. 11: 1045-1058. PMID 11978764 |
0.456 |
|
| 2002 |
Bergstrom DA, Penn BH, Strand A, Perry RL, Rudnicki MA, Tapscott SJ. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Molecular Cell. 9: 587-600. PMID 11931766 DOI: 10.1016/S1097-2765(02)00481-1 |
0.399 |
|
| 2001 |
Franklin A, Kao A, Tapscott S, Unis A. NeuroD homologue expression during cortical development in the human brain Journal of Child Neurology. 16: 849-853. PMID 11732772 DOI: 10.1177/08830738010160111201 |
0.386 |
|
| 2001 |
Bergstrom DA, Tapscott SJ. Molecular distinction between specification and differentiation in the myogenic basic helix-loop-helix transcription factor family. Molecular and Cellular Biology. 21: 2404-12. PMID 11259589 DOI: 10.1128/MCB.21.7.2404-2412.2001 |
0.489 |
|
| 2001 |
Snider L, Thirlwell H, Miller JR, Moon RT, Groudine M, Tapscott SJ. Inhibition of Tcf3 binding by I-mfa domain proteins Molecular and Cellular Biology. 21: 1866-1873. PMID 11238923 DOI: 10.1128/MCB.21.5.1866-1873.2001 |
0.331 |
|
| 2000 |
Murray RC, Tapscott SJ, Petersen JW, Calof AL, McCormick MB. A fragment of the Neurogenin1 gene confers regulated expression of a reporter gene in vitro and in vivo Developmental Dynamics. 218: 189-194. PMID 10822270 DOI: 10.1002/(Sici)1097-0177(200005)218:1<189::Aid-Dvdy16>3.0.Co;2-4 |
0.389 |
|
| 2000 |
Luthi-Carter R, Strand A, Peters NL, Solano SM, Hollingsworth ZR, Menon AS, Frey AS, Spektor BS, Penney EB, Schilling G, Ross CA, Borchelt DR, Tapscott SJ, Young AB, Cha JH, et al. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Human Molecular Genetics. 9: 1259-71. PMID 10814708 DOI: 10.1093/Hmg/9.9.1259 |
0.302 |
|
| 2000 |
Farah MH, Olson JM, Sucic HB, Hume RI, Tapscott SJ, Turner DL. Generation of neurons by transient expression of neural bHLH proteins in mammalian cells. Development (Cambridge, England). 127: 693-702. PMID 10648228 |
0.467 |
|
| 1999 |
Knoepfler PS, Bergstrom DA, Uetsuki T, Dac-Korytko I, Sun YH, Wright WE, Tapscott SJ, Kamps MP. A conserved motif N-terminal to the DNA-binding domains of myogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1. Nucleic Acids Research. 27: 3752-61. PMID 10471746 DOI: 10.1093/Nar/27.18.3752 |
0.32 |
|
| 1999 |
Kablar B, Krastel K, Ying C, Tapscott SJ, Goldhamer DJ, Rudnicki MA. Myogenic determination occurs independently in somites and limb buds Developmental Biology. 206: 219-231. PMID 9986734 DOI: 10.1006/Dbio.1998.9126 |
0.47 |
|
| 1998 |
Asakura A, Tapscott SJ. Apoptosis of epaxial myotome in Danforth's shorttail (Sd) mice in somites that form following notochord degeneration Developmental Biology. 203: 276-289. PMID 9808779 DOI: 10.1006/dbio.1998.9050 |
0.386 |
|
| 1998 |
Kraut N, Snider L, Chen CMA, Tapscott SJ, Groudine M. Requirement of the mouse I-mfa gene for placental development and skeletal patterning Embo Journal. 17: 6276-6288. PMID 9799236 DOI: 10.1093/emboj/17.21.6276 |
0.416 |
|
| 1998 |
Gredinger E, Gerber AN, Tamir Y, Tapscott SJ, Bengal E. Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells Journal of Biological Chemistry. 273: 10436-10444. PMID 9553102 DOI: 10.1074/jbc.273.17.10436 |
0.473 |
|
| 1997 |
Kablar B, Krastel K, Ying C, Asakura A, Tapscott SJ, Rudnicki MA. MyoD and Myf-5 differentially regulate the development of limb versus trunk skeletal muscle Development. 124: 4729-4738. PMID 9428409 |
0.359 |
|
| 1997 |
Otten AD, Firpo EJ, Gerber AN, Brody LL, Roberts JM, Tapscott SJ. Inactivation of MyoD-mediated expression of p21 in tumor cell lines Cell Growth and Differentiation. 8: 1151-1160. PMID 9372238 |
0.316 |
|
| 1997 |
Klesert TR, Otten AD, Bird TD, Tapscott SJ. Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. Nature Genetics. 16: 402-6. PMID 9241282 DOI: 10.1038/Ng0897-402 |
0.337 |
|
| 1997 |
Gerber AN, Klesert TR, Bergstrom DA, Tapscott SJ. Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: A mechanism for lineage determination in myogenesis Genes and Development. 11: 436-450. PMID 9042858 |
0.403 |
|
| 1997 |
Rostomily RC, Berger MS, Bermingham-McDonogh O, Olson J, Winn HR, Tapscott S. The Expression of Neurogenic Genes in Primitive Neuroectodermal Tumors (PNETs) Neurosurgery. 41: 734-734. DOI: 10.1097/00006123-199709000-00110 |
0.353 |
|
| 1996 |
McCormick MB, Tamimi RM, Snider L, Asakura A, Bergstrom D, Tapscott SJ. neuroD2 and neuroD3: Distinct expression patterns and transcriptional activation potentials within the neuroD gene family Molecular and Cellular Biology. 16: 5792-5800. PMID 8816493 |
0.396 |
|
| 1996 |
Fiddler TA, Smith L, Tapscott SJ, Thayer MJ. Amplification of MDM2 inhibits MyoD-mediated myogenesis Molecular and Cellular Biology. 16: 5048-5057. PMID 8756663 |
0.318 |
|
| 1995 |
Asakura A, Lyons GE, Tapscott SJ. The Regulation of MyoD Gene Expression: Conserved Elements Mediate Expression in Embryonic Axial Muscle Developmental Biology. 171: 386-398. PMID 7556922 DOI: 10.1006/dbio.1995.1290 |
0.491 |
|
| 1993 |
Tapscott SJ, Thayer MJ, Weintraub H. Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. Science (New York, N.Y.). 259: 1450-3. PMID 8383879 DOI: 10.1126/Science.8383879 |
0.672 |
|
| 1993 |
Sancho S, Mongini T, Tanji K, Tapscott SJ, Walker WF, Weintraub H, Miller AD, Miranda AF. Analysis of dystrophin expression after activation of myogenesis in amniocytes, chorionic-villus cells, and fibroblasts. A new method for diagnosing Duchenne's muscular dystrophy. The New England Journal of Medicine. 329: 915-20. PMID 8361505 DOI: 10.1056/NEJM199309233291303 |
0.617 |
|
| 1993 |
Hughes SM, Taylor JM, Tapscott SJ, Gurley CM, Carter WJ, Peterson CA. Selective accumulation of MyoD and Myogenin mRNAs in fast and slow adult skeletal muscle is controlled by innervation and hormones Development. 118: 1137-1147. PMID 8269844 |
0.455 |
|
| 1992 |
Krause M, Fire A, White-Harrison S, Weintraub H, Tapscott S. Functional conservation of nematode and vertebrate myogenic regulatory factors. Journal of Cell Science. Supplement. 16: 111-5. PMID 1338434 DOI: 10.1242/Jcs.1992.Supplement_16.13 |
0.688 |
|
| 1992 |
Johnston LA, Tapscott SJ, Eisen H. Sodium butyrate inhibits myogenesis by interfering with the transcriptional activation function of MyoD and myogenin. Molecular and Cellular Biology. 12: 5123-30. PMID 1328872 DOI: 10.1128/Mcb.12.11.5123 |
0.46 |
|
| 1992 |
Tapscott SJ, Lassar AB, Weintraub H. A novel myoblast enhancer element mediates MyoD transcription. Molecular and Cellular Biology. 12: 4994-5003. PMID 1328870 |
0.761 |
|
| 1992 |
Kim SJ, Kim KY, Tapscott SJ, Winokur TS, Park K, Fujiki H, Weintraub H, Roberts AB. Inhibition of protein phosphatases blocks myogenesis by first altering MyoD binding activity. The Journal of Biological Chemistry. 267: 15140-5. PMID 1321827 |
0.645 |
|
| 1992 |
Bengal E, Ransone L, Scharfmann R, Dwarki VJ, Tapscott SJ, Weintraub H, Verma IM. Functional antagonism between c-Jun and MyoD proteins: a direct physical association. Cell. 68: 507-19. PMID 1310896 DOI: 10.1016/0092-8674(92)90187-H |
0.629 |
|
| 1991 |
Tapscott SJ, Weintraub H. MyoD and the regulation of myogenesis by helix-loop-helix proteins. The Journal of Clinical Investigation. 87: 1133-8. PMID 1849142 DOI: 10.1172/JCI115109 |
0.53 |
|
| 1991 |
Weintraub H, Davis R, Tapscott S, Thayer M, Krause M, Benezra R, Blackwell TK, Turner D, Rupp R, Hollenberg S. The myoD gene family: nodal point during specification of the muscle cell lineage. Science (New York, N.Y.). 251: 761-6. PMID 1846704 DOI: 10.1126/Science.1846704 |
0.814 |
|
| 1991 |
Weintraub H, Dwarki VJ, Verma I, Davis R, Hollenberg S, Snider L, Lassar A, Tapscott SJ. Muscle-specific transcriptional activation by MyoD. Genes & Development. 5: 1377-86. PMID 1651276 DOI: 10.1101/Gad.5.8.1377 |
0.741 |
|
| 1991 |
Weintraub H, Hauschka S, Tapscott SJ. The MCK enhancer contains a p53 responsive element. Proceedings of the National Academy of Sciences of the United States of America. 88: 4570-1. PMID 1647009 DOI: 10.1073/Pnas.88.11.4570 |
0.548 |
|
| 1990 |
Tapscott SJ, Davis RL, Lassar AB, Weintraub H. MyoD: a regulatory gene of skeletal myogenesis. Advances in Experimental Medicine and Biology. 280: 3-5; discussion 5-6. PMID 2248151 DOI: 10.1007/978-1-4684-5865-7_1 |
0.791 |
|
| 1990 |
Benezra R, Davis RL, Lassar A, Tapscott S, Thayer M, Lockshon D, Weintraub H. Id: a negative regulator of helix-loop-helix DNA binding proteins. Control of terminal myogenic differentiation. Annals of the New York Academy of Sciences. 599: 1-11. PMID 2171390 DOI: 10.1111/J.1749-6632.1990.Tb42359.X |
0.748 |
|
| 1989 |
Weintraub H, Tapscott SJ, Davis RL, Thayer MJ, Adam MA, Lassar AB, Miller AD. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proceedings of the National Academy of Sciences of the United States of America. 86: 5434-8. PMID 2748593 DOI: 10.1073/Pnas.86.14.5434 |
0.781 |
|
| 1989 |
Davis RL, Cheng PF, Lassar AB, Thayer M, Tapscott S, Weintraub H. MyoD and achaete-scute: 4-5 amino acids distinguishes myogenesis from neurogenesis. Princess Takamatsu Symposia. 20: 267-78. PMID 2562185 |
0.741 |
|
| 1989 |
Tapscott SJ, Lassar AB, Davis RL, Weintraub H. 5-bromo-2'-deoxyuridine blocks myogenesis by extinguishing expression of MyoD1. Science (New York, N.Y.). 245: 532-6. PMID 2547249 DOI: 10.1126/Science.2547249 |
0.784 |
|
| 1989 |
Thayer MJ, Tapscott SJ, Davis RL, Wright WE, Lassar AB, Weintraub H. Positive autoregulation of the myogenic determination gene MyoD1. Cell. 58: 241-8. PMID 2546677 DOI: 10.1016/0092-8674(89)90838-6 |
0.745 |
|
| 1988 |
Tapscott SJ, Davis RL, Thayer MJ, Cheng PF, Weintraub H, Lassar AB. MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science (New York, N.Y.). 242: 405-11. PMID 3175662 DOI: 10.1126/Science.3175662 |
0.744 |
|
| 1984 |
Bennett GS, Tapscott SJ, DiLullo C, Holtzer H. Differential binding of antibodies against the neurofilament triplet proteins in different avian neurons. Brain Research. 304: 291-302. PMID 6430468 DOI: 10.1016/0006-8993(84)90333-0 |
0.481 |
|
| 1983 |
Dlugosz AA, Tapscott SJ, Holtzer H. Effects of phorbol 12-myristate 13-acetate on the differentiation program of embryonic chick skeletal myoblasts. Cancer Research. 43: 2780-9. PMID 6342759 |
0.662 |
|
| 1982 |
Holtzer H, Bennett GS, Tapscott SJ, Croop JM, Toyama Y. Intermediate-size filaments: changes in synthesis and distribution in cells of the myogenic and neurogenic lineages. Cold Spring Harbor Symposia On Quantitative Biology. 46: 317-29. PMID 6955084 DOI: 10.1101/Sqb.1982.046.01.033 |
0.482 |
|
| 1981 |
Tapscott SJ, Bennett GS, Toyama Y, Kleinbart F, Holtzer H. Intermediate filament proteins in the developing chick spinal cord. Developmental Biology. 86: 40-54. PMID 7197239 DOI: 10.1016/0012-1606(81)90313-4 |
0.558 |
|
| 1981 |
Tapscott SJ, Bennett GS, Holtzer H. Neuronal precursor cells in the chick neural tube express neurofilament proteins. Nature. 292: 836-8. PMID 6791030 DOI: 10.1038/292836a0 |
0.571 |
|
| 1981 |
Bennett GS, Tapscott SJ, Kleinbart FA, Antin PB, Holtzer H. Different proteins associated with 10-nanometer filaments in cultured chick neurons and nonneuronal cells. Science (New York, N.Y.). 212: 567-9. PMID 6163217 DOI: 10.1126/Science.6163217 |
0.535 |
|
| 1981 |
Antin PB, Forry-Schaudies S, Friedman TM, Tapscott SJ, Holtzer H. Taxol induces postmitotic myoblasts to assemble interdigitating microtubule-myosin arrays that exclude actin filaments. The Journal of Cell Biology. 90: 300-8. PMID 6116716 DOI: 10.1083/Jcb.90.2.300 |
0.487 |
|
| 1979 |
Schmid E, Tapscott S, Bennett GS, Croop J, Fellini SA, Holtzer H, Franke WW. Differential location of different types of intermediate-sized filaments in various tissues of the chicken embryo. Differentiation; Research in Biological Diversity. 15: 27-40. PMID 93557 DOI: 10.1111/j.1432-0436.1979.tb01031.x |
0.578 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1997 |
Rostomily RC, Bermingham-McDonogh O, Berger MS, Tapscott SJ, Reh TA, Olson JM. Expression of neurogenic basic helix-loop-helix genes in primitive neuroectodermal tumors. Cancer Research. 57: 3526-31. PMID 9270024 |
0.299 |
|
| 2007 |
O'Rourke JR, Georges SA, Seay HR, Tapscott SJ, McManus MT, Goldhamer DJ, Swanson MS, Harfe BD. Essential role for Dicer during skeletal muscle development. Developmental Biology. 311: 359-68. PMID 17936265 DOI: 10.1016/J.Ydbio.2007.08.032 |
0.299 |
|
| 2012 |
Fong AP, Yao Z, Zhong JW, Cao Y, Ruzzo WL, Gentleman RC, Tapscott SJ. Genetic and epigenetic determinants of neurogenesis and myogenesis. Developmental Cell. 22: 721-35. PMID 22445365 DOI: 10.1016/J.Devcel.2012.01.015 |
0.296 |
|
| 2012 |
Lemmers RJ, Tawil R, Petek LM, Balog J, Block GJ, Santen GW, Amell AM, van der Vliet PJ, Almomani R, Straasheijm KR, Krom YD, Klooster R, Sun Y, den Dunnen JT, Helmer Q, ... ... Tapscott SJ, et al. Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nature Genetics. 44: 1370-4. PMID 23143600 DOI: 10.1038/ng.2454 |
0.296 |
|
| 2009 |
Snider L, Asawachaicharn A, Tyler AE, Geng LN, Petek LM, Maves L, Miller DG, Lemmers RJ, Winokur ST, Tawil R, van der Maarel SM, Filippova GN, Tapscott SJ. RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. Human Molecular Genetics. 18: 2414-30. PMID 19359275 DOI: 10.1093/hmg/ddp180 |
0.294 |
|
| 1998 |
Cook DL, Gerber AN, Tapscott SJ. Modeling stochastic gene expression: implications for haploinsufficiency. Proceedings of the National Academy of Sciences of the United States of America. 95: 15641-6. PMID 9861023 DOI: 10.1073/pnas.95.26.15641 |
0.294 |
|
| 2015 |
Statland JM, Odrzywolski KJ, Shah B, Henderson D, Fricke AF, van der Maarel SM, Tapscott SJ, Tawil R. Immunohistochemical Characterization of Facioscapulohumeral Muscular Dystrophy Muscle Biopsies. Journal of Neuromuscular Diseases. 2: 291-299. PMID 26345300 DOI: 10.3233/JND-150077 |
0.294 |
|
| 2000 |
Klesert TR, Cho DH, Clark JI, Maylie J, Adelman J, Snider L, Yuen EC, Soriano P, Tapscott SJ. Mice deficient in Six5 develop cataracts: Implications for myotonic dystrophy Nature Genetics. 25: 105-109. PMID 10802667 DOI: 10.1038/75490 |
0.292 |
|
| 2021 |
Lemmers RJLF, van der Vliet PJ, Blatnik A, Balog J, Zidar J, Henderson D, Goselink R, Tapscott SJ, Voermans NC, Tawil R, Padberg GWAM, van Engelen BG, van der Maarel SM. Chromosome 10q-linked FSHD identifies as principal disease gene. Journal of Medical Genetics. PMID 33436523 DOI: 10.1136/jmedgenet-2020-107041 |
0.292 |
|
| 1996 |
Gerber AN, Tapscott SJ. Tumor cell complementation groups based on myogenic potential: Evidence for inactivation of loci required for basic helix-loop-helix protein activity Molecular and Cellular Biology. 16: 3901-3908. PMID 8668208 |
0.284 |
|
| 2013 |
Marotta M, Chen X, Watanabe T, Faber PW, Diede SJ, Tapscott S, Tubbs R, Kondratova A, Stephens R, Tanaka H. Homology-mediated end-capping as a primary step of sister chromatid fusion in the breakage-fusion-bridge cycles. Nucleic Acids Research. 41: 9732-40. PMID 23975201 DOI: 10.1093/Nar/Gkt762 |
0.282 |
|
| 2014 |
Wang Z, Halbert CL, Lee D, Butts T, Tapscott SJ, Storb R, Miller AD. Elimination of contaminating cap genes in AAV vector virions reduces immune responses and improves transgene expression in a canine gene therapy model. Gene Therapy. 21: 363-70. PMID 24500525 DOI: 10.1038/gt.2014.4 |
0.28 |
|
| 2013 |
Sacconi S, Lemmers RJ, Balog J, van der Vliet PJ, Lahaut P, van Nieuwenhuizen MP, Straasheijm KR, Debipersad RD, Vos-Versteeg M, Salviati L, Casarin A, Pegoraro E, Tawil R, Bakker E, Tapscott SJ, et al. The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1. American Journal of Human Genetics. 93: 744-51. PMID 24075187 DOI: 10.1016/j.ajhg.2013.08.004 |
0.277 |
|
| 2010 |
Lemmers RJ, van der Vliet PJ, Klooster R, Sacconi S, Camaño P, Dauwerse JG, Snider L, Straasheijm KR, van Ommen GJ, Padberg GW, Miller DG, Tapscott SJ, Tawil R, Frants RR, van der Maarel SM. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science (New York, N.Y.). 329: 1650-3. PMID 20724583 DOI: 10.1126/Science.1189044 |
0.276 |
|
| 2008 |
Parker MH, Kuhr C, Tapscott SJ, Storb R. Hematopoietic cell transplantation provides an immune-tolerant platform for myoblast transplantation in dystrophic dogs. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1340-6. PMID 18500253 DOI: 10.1038/mt.2008.102 |
0.275 |
|
| 2016 |
Maarel SVd, Boogaard MVd, Lemmers R, Balog J, Mitsuhashi S, Kriek M, Wohlgemuth M, Kooi EVd, Auranen M, Udd B, Tol MV, Nishino I, Tawil R, Tapscott S, Engelen Bv. Gene variants in SMCHD1 and DNMT3B modify the risk for FSHD Neuromuscular Disorders. 26. DOI: 10.1016/J.Nmd.2016.06.241 |
0.271 |
|
| 1995 |
Otten AD, Tapscott SJ. Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure Proceedings of the National Academy of Sciences of the United States of America. 92: 5465-5469. PMID 7777532 DOI: 10.1073/pnas.92.12.5465 |
0.267 |
|
| 2001 |
Olson JM, Asakura A, Snider L, Hawkes R, Strand A, Stoeck J, Hallahan A, Pritchard J, Tapscott SJ. NeuroD2 is necessary for development and survival of central nervous system neurons Developmental Biology. 234: 174-187. PMID 11356028 DOI: 10.1006/Dbio.2001.0245 |
0.267 |
|
| 2001 |
Thomas JG, Olson JM, Tapscott SJ, Zhao P. An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles Genome Research. 11: 1227-1236. PMID 11435405 DOI: 10.1101/Gr.165101 |
0.264 |
|
| 2019 |
Goossens R, van den Boogaard ML, Lemmers RJLF, Balog J, van der Vliet PJ, Willemsen IM, Schouten J, Maggio I, van der Stoep N, Hoeben RC, Tapscott SJ, Geijsen N, Gonçalves MAFV, Sacconi S, Tawil R, et al. Intronic variants in FSHD: testing the potential for CRISPR-Cas9 genome editing. Journal of Medical Genetics. PMID 31676591 DOI: 10.1136/jmedgenet-2019-106402 |
0.263 |
|
| 2003 |
Hallahan AR, Pritchard JI, Chandraratna RA, Ellenbogen RG, Geyer JR, Overland RP, Strand AD, Tapscott SJ, Olson JM. BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nature Medicine. 9: 1033-8. PMID 12872164 DOI: 10.1038/Nm904 |
0.259 |
|
| 2022 |
Crist SB, Nemkov T, Dumpit RF, Dai J, Tapscott SJ, True LD, Swarbrick A, Sullivan LB, Nelson PS, Hansen KC, Ghajar CM. Publisher Correction: Unchecked oxidative stress in skeletal muscle prevents outgrowth of disseminated tumour cells. Nature Cell Biology. PMID 35610516 DOI: 10.1038/s41556-022-00945-5 |
0.259 |
|
| 2015 |
Statland JM, Shah B, Henderson D, Van Der Maarel S, Tapscott SJ, Tawil R. Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies. Muscle & Nerve. PMID 25704033 DOI: 10.1002/mus.24621 |
0.256 |
|
| 2021 |
Wang LH, Johnstone LM, Bindschadler M, Tapscott SJ, Friedman SD. Adapting MRI as a clinical outcome measure for a facioscapulohumeral muscular dystrophy trial of prednisone and tacrolimus: case report. Bmc Musculoskeletal Disorders. 22: 56. PMID 33422031 DOI: 10.1186/s12891-020-03910-1 |
0.254 |
|
| 2010 |
Wang Z, Storb R, Lee D, Kushmerick MJ, Chu B, Berger C, Arnett A, Allen J, Chamberlain JS, Riddell SR, Tapscott SJ. Immune responses to AAV in canine muscle monitored by cellular assays and noninvasive imaging. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 617-24. PMID 20040912 DOI: 10.1038/Mt.2009.294 |
0.253 |
|
| 2011 |
Wang Z, Tapscott SJ, Chamberlain JS, Storb R. Immunity and AAV-Mediated Gene Therapy for Muscular Dystrophies in Large Animal Models and Human Trials. Frontiers in Microbiology. 2: 201. PMID 21980317 DOI: 10.3389/fmicb.2011.00201 |
0.249 |
|
| 2001 |
Penn BH, Berkes CA, Bergstrom DA, Tapscott SJ. How to MEK muscle. Molecular Cell. 8: 245-6. PMID 11545725 DOI: 10.1016/S1097-2765(01)00331-8 |
0.248 |
|
| 2017 |
de Greef JC, Krom YD, den Hamer B, Snider L, Hiramuki Y, van den Akker RFP, Breslin K, Pakusch M, Salvatori DCF, Slütter B, Tawil R, Blewitt ME, Tapscott SJ, van der Maarel SM. Smchd1 haploinsufficiency exacerbates the phenotype of a transgenic FSHD1 mouse model. Human Molecular Genetics. PMID 29281018 DOI: 10.1093/hmg/ddx437 |
0.244 |
|
| 2009 |
Wang Z, Chamberlain JS, Tapscott SJ, Storb R. Gene therapy in large animal models of muscular dystrophy. Ilar Journal / National Research Council, Institute of Laboratory Animal Resources. 50: 187-98. PMID 19293461 |
0.243 |
|
| 2012 |
Wang Z, Storb R, Tapscott SJ, Riddell S. Analyzing cellular immunity to AAV in a canine model using ELISPOT assay. Methods in Molecular Biology (Clifton, N.J.). 792: 65-74. PMID 21956501 DOI: 10.1007/978-1-61779-325-7_5 |
0.242 |
|
| 2017 |
Greef Jd, Krom Y, Hamer Bd, Snider L, Hiramuki Y, Akker Rvd, Salvatori D, Tawil R, Blewitt M, Tapscott S, Maarel Svd. P.350 - Smchd1 haploinsufficiency exacerbates the phenotype of a transgenic FSHD1 mouse model Neuromuscular Disorders. 27. DOI: 10.1016/J.Nmd.2017.06.390 |
0.241 |
|
| 2013 |
Dey J, Dubuc AM, Pedro KD, Thirstrup D, Mecham B, Northcott PA, Wu X, Shih D, Tapscott SJ, LeBlanc M, Taylor MD, Olson JM. MyoD is a tumor suppressor gene in medulloblastoma. Cancer Research. 73: 6828-37. PMID 24092238 DOI: 10.1158/0008-5472.Can-13-0730-T |
0.241 |
|
| 2013 |
Yao Z, Fong AP, Cao Y, Ruzzo WL, Gentleman RC, Tapscott SJ. Comparison of endogenous and overexpressed MyoD shows enhanced binding of physiologically bound sites. Skeletal Muscle. 3: 8. PMID 23566431 DOI: 10.1186/2044-5040-3-8 |
0.239 |
|
| 2007 |
Ladd PD, Smith LE, Rabaia NA, Moore JM, Georges SA, Hansen RS, Hagerman RJ, Tassone F, Tapscott SJ, Filippova GN. An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Human Molecular Genetics. 16: 3174-87. PMID 17921506 DOI: 10.1093/hmg/ddm293 |
0.239 |
|
| 2004 |
Klezovitch O, Fernandez TE, Tapscott SJ, Vasioukhin V. Loss of cell polarity causes severe brain dysplasia in Lgl1 knockout mice Genes and Development. 18: 559-571. PMID 15037549 DOI: 10.1101/Gad.1178004 |
0.238 |
|
| 2002 |
Tanaka H, Tapscott SJ, Trask BJ, Yao MC. Short inverted repeats initiate gene amplification through the formation of a large DNA palindrome in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America. 99: 8772-7. PMID 12060719 DOI: 10.1073/pnas.132275999 |
0.235 |
|
| 1994 |
Tapscott SJ, Miller AD, Olson JM, Berger MS, Groudine M, Spence AM. Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection. Proceedings of the National Academy of Sciences of the United States of America. 91: 8185-9. PMID 8058777 DOI: 10.1073/Pnas.91.17.8185 |
0.232 |
|
| 2011 |
MacQuarrie KL, Fong AP, Morse RH, Tapscott SJ. Genome-wide transcription factor binding: beyond direct target regulation. Trends in Genetics : Tig. 27: 141-8. PMID 21295369 DOI: 10.1016/j.tig.2011.01.001 |
0.232 |
|
| 2012 |
Balog J, Miller D, Sanchez-Curtailles E, Carbo-Marques J, Block G, Potman M, de Knijff P, Lemmers RJ, Tapscott SJ, van der Maarel SM. Epigenetic regulation of the X-chromosomal macrosatellite repeat encoding for the cancer/testis gene CT47. European Journal of Human Genetics : Ejhg. 20: 185-91. PMID 21811308 DOI: 10.1038/ejhg.2011.150 |
0.231 |
|
| 2013 |
Macquarrie KL, Yao Z, Fong AP, Tapscott SJ. Genome-wide binding of the basic helix-loop-helix myogenic inhibitor musculin has substantial overlap with MyoD: implications for buffering activity. Skeletal Muscle. 3: 26. PMID 24175993 DOI: 10.1186/2044-5040-3-26 |
0.228 |
|
| 2012 |
Mahoney SE, Yao Z, Keyes CC, Tapscott SJ, Diede SJ. Genome-wide DNA methylation studies suggest distinct DNA methylation patterns in pediatric embryonal and alveolar rhabdomyosarcomas. Epigenetics. 7: 400-8. PMID 22419069 DOI: 10.4161/epi.19463 |
0.223 |
|
| 2015 |
Fong AP, Yao Z, Zhong JW, Johnson NM, Farr GH, Maves L, Tapscott SJ. Conversion of MyoD to a neurogenic factor: binding site specificity determines lineage. Cell Reports. 10: 1937-46. PMID 25801030 DOI: 10.1016/j.celrep.2015.02.055 |
0.22 |
|
| 2017 |
Lemmers RJ, van der Vliet PJ, Balog J, Goeman JJ, Arindrarto W, Krom YD, Straasheijm KR, Debipersad RD, Özel G, Sowden J, Snider L, Mul K, Sacconi S, van Engelen B, Tapscott SJ, et al. Deep characterization of a common D4Z4 variant identifies biallelic DUX4 expression as a modifier for disease penetrance in FSHD2. European Journal of Human Genetics : Ejhg. PMID 29162933 DOI: 10.1038/s41431-017-0015-0 |
0.216 |
|
| 1981 |
Bennett GS, Tapscott SJ, Kleinbart FA, Antin PB, Holtzer H. Different proteins associated with 10-nanometer filaments in cultured chick neurons and nonneuronal cells Science. 212: 569-571. |
0.21 |
|
| 2022 |
van den Heuvel A, Lassche S, Mul K, Greco A, San León Granado D, Heerschap A, Küsters B, Tapscott SJ, Voermans NC, van Engelen BGM, van der Maarel SM. Facioscapulohumeral dystrophy transcriptome signatures correlate with different stages of disease and are marked by different MRI biomarkers. Scientific Reports. 12: 1426. PMID 35082321 DOI: 10.1038/s41598-022-04817-8 |
0.209 |
|
| 2012 |
Balog J, Thijssen PE, de Greef JC, Shah B, van Engelen BG, Yokomori K, Tapscott SJ, Tawil R, van der Maarel SM. Correlation analysis of clinical parameters with epigenetic modifications in the DUX4 promoter in FSHD. Epigenetics. 7: 579-84. PMID 22522912 DOI: 10.4161/Epi.20001 |
0.206 |
|
| 2010 |
Tanaka H, Bergstrom DA, Yao M, Tapscott SJ. Erratum: Corrigendum: Widespread and nonrandom distribution of DNA palindromes in cancer cells provides a structural platform for subsequent gene amplification Nature Genetics. 42: 361-361. DOI: 10.1038/ng0410-361c |
0.204 |
|
| 2021 |
Wang LH, Shaw DWW, Faino A, Budech CB, Lewis LM, Statland J, Eichinger K, Tapscott SJ, Tawil RN, Friedman SD. Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy. Bmc Musculoskeletal Disorders. 22: 262. PMID 33691664 DOI: 10.1186/s12891-021-04134-7 |
0.203 |
|
| 1992 |
Dias P, Parham DM, Shapiro DN, Tapscott SJ, Houghton PJ. Monoclonal antibodies to the myogenic regulatory protein MyoD1: epitope mapping and diagnostic utility. Cancer Research. 52: 6431-9. PMID 1384962 |
0.202 |
|
| 2016 |
van den Boogaard ML, Lemmers RJ, Balog J, Wohlgemuth M, Auranen M, Mitsuhashi S, van der Vliet PJ, Straasheijm KR, van den Akker RF, Kriek M, Laurense-Bik ME, Raz V, van Ostaijen-Ten Dam MM, Hansson KB, van der Kooi EL, ... ... Tapscott SJ, et al. Mutations in DNMT3B Modify Epigenetic Repression of the D4Z4 Repeat and the Penetrance of Facioscapulohumeral Dystrophy. American Journal of Human Genetics. 98: 1020-9. PMID 27153398 DOI: 10.1016/j.ajhg.2016.03.013 |
0.202 |
|
| 2010 |
Halbert CL, Madtes DK, Vaughan AE, Wang Z, Storb R, Tapscott SJ, Miller AD. Expression of Human α1-Antitrypsin in Mice and Dogs Following AAV6 Vector-mediated Gene Transfer to the Lungs. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 1165-1172. PMID 28178495 DOI: 10.1038/mt.2010.51 |
0.196 |
|
| 2010 |
Halbert CL, Madtes DK, Vaughan AE, Wang Z, Storb R, Tapscott SJ, Miller AD. Expression of human alpha1-antitrypsin in mice and dogs following AAV6 vector-mediated gene transfer to the lungs. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 1165-72. PMID 20372105 DOI: 10.1038/Mt.2010.51 |
0.194 |
|
| 2003 |
Maley CC, Tapscott SJ. Selective instability: maternal effort and the evolution of gene activation and deactivation rates. Artificial Life. 9: 317-26. PMID 14556689 DOI: 10.1162/106454603322392488 |
0.189 |
|
| 2000 |
Tapscott SJ. Deconstructing myotonic dystrophy Science. 289: 1701-1702. PMID 11001736 DOI: 10.1126/science.289.5485.1701 |
0.189 |
|
| 2006 |
Tanaka H, Bergstrom DA, Yao MC, Tapscott SJ. Large DNA palindromes as a common form of structural chromosome aberrations in human cancers. Human Cell. 19: 17-23. PMID 16643603 DOI: 10.1111/j.1749-0774.2005.00003.x |
0.189 |
|
| 2010 |
Diede S, Tapscott S. Protocol for genome-wide analysis of palindrome formation Nature Protocols. DOI: 10.1038/Nprot.2010.59 |
0.188 |
|
| 2016 |
Goossens R, Balog J, Lemmers J, Boogaard Mvd, Vliet Pvd, Donlin-Smith C, Nations S, Kriek M, Ruivenkamp C, Heard P, Bakker B, Tapscott S, Cody J, Tawil R, Maarel Svd. Monosomy 18p: Risks for developing FSHD Neuromuscular Disorders. 26. DOI: 10.1016/J.Nmd.2016.06.295 |
0.182 |
|
| 2023 |
Tihaya MS, Mul K, Balog J, de Greef JC, Tapscott SJ, Tawil R, Statland JM, van der Maarel SM. Facioscapulohumeral muscular dystrophy: the road to targeted therapies. Nature Reviews. Neurology. 19: 91-108. PMID 36627512 DOI: 10.1038/s41582-022-00762-2 |
0.18 |
|
| 1990 |
Jones PA, Wolkowicz MJ, Rideout WM, Gonzales FA, Marziasz CM, Coetzee GA, Tapscott SJ. De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines Proceedings of the National Academy of Sciences of the United States of America. 87: 6117-6121. PMID 2385586 DOI: 10.1073/Pnas.87.16.6117 |
0.177 |
|
| 2001 |
Filippova GN, Thienes CP, Penn BH, Cho DH, Hu YJ, Moore JM, Klesert TR, Lobanenkov VV, Tapscott SJ. CTCF-binding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus Nature Genetics. 28: 335-343. PMID 11479593 DOI: 10.1038/ng570 |
0.177 |
|
| 2015 |
van den Boogaard ML, Jfl Lemmers R, Camaño P, van der Vliet PJ, Voermans N, van Engelen BG, Lopez de Munain A, Tapscott SJ, van der Stoep N, Tawil R, van der Maarel SM. Double SMCHD1 variants in FSHD2: the synergistic effect of two SMCHD1 variants on D4Z4 hypomethylation and disease penetrance in FSHD2. European Journal of Human Genetics : Ejhg. PMID 25782668 DOI: 10.1038/ejhg.2015.55 |
0.176 |
|
| 1996 |
Tamimi R, Steingrimsson E, Copeland NG, Dyer-Montgomery K, Lee JE, Hernandez R, Jenkins NA, Tapscott SJ. The NEUROD gene maps to human chromosome 2q32 and mouse chromosome 2 Genomics. 34: 418-421. PMID 8786144 DOI: 10.1006/Geno.1996.0306 |
0.176 |
|
| 2000 |
Ashizawa T, Gonzales I, Ohsawa N, Singer RH, Devillers M, Balasubramanyam A, Cooper TA, Khajavi M, Lia-Baldini AS, Miller G, Philips AV, Timchenko LT, Waring J, Yamagata H, Barbet JP, ... ... Tapscott SJ, et al. New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1) Neurology. 54: 1218-1221. PMID 10746587 DOI: 10.1212/Wnl.54.6.1218 |
0.172 |
|
| 2008 |
Libby RT, Hagerman KA, Pineda VV, Lau R, Cho DH, Baccam SL, Axford MM, Cleary JD, Moore JM, Sopher BL, Tapscott SJ, Filippova GN, Pearson CE, La Spada AR. CTCF cis-regulates trinucleotide repeat instability in an epigenetic manner: a novel basis for mutational hot spot determination. Plos Genetics. 4: e1000257. PMID 19008940 DOI: 10.1371/Journal.Pgen.1000257 |
0.171 |
|
| 1998 |
Tapscott SJ, Klesert TR, Widrow RJ, Stöger R, Laird CD. Fragile-X syndrome and myotonic dystrophy: parallels and paradoxes. Current Opinion in Genetics & Development. 8: 245-53. PMID 9610417 DOI: 10.1016/S0959-437X(98)80148-2 |
0.169 |
|
| 2006 |
Ince-Dunn G, Hall BJ, Hu SC, Ripley B, Huganir RL, Olson JM, Tapscott SJ, Ghosh A. Regulation of thalamocortical patterning and synaptic maturation by NeuroD2. Neuron. 49: 683-95. PMID 16504944 DOI: 10.1016/J.Neuron.2006.01.031 |
0.168 |
|
| 2018 |
Hiramuki Y, Tapscott SJ. Identification of SMCHD1 domains for nuclear localization, homo-dimerization, and protein cleavage. Skeletal Muscle. 8: 24. PMID 30071896 DOI: 10.1186/s13395-018-0172-z |
0.166 |
|
| 2005 |
Tanaka H, Bergstrom DA, Yao MC, Tapscott SJ. Widespread and nonrandom distribution of DNA palindromes in cancer cells provides a structural platform for subsequent gene amplification. Nature Genetics. 37: 320-7. PMID 15711546 DOI: 10.1038/ng1515 |
0.166 |
|
| 2006 |
Tapscott SJ. Rhabdomyosarcomas Principles of Molecular Medicine. 700-703. DOI: 10.1007/978-1-59259-963-9_71 |
0.161 |
|
| 2021 |
Wong CJ, Wang L, Holers VM, Frazer-Abel A, van der Maarel SM, Tawil R, Statland JM, Tapscott SJ, Network R. Elevated plasma complement components in facioscapulohumeral dystrophy. Human Molecular Genetics. PMID 34919696 DOI: 10.1093/hmg/ddab364 |
0.161 |
|
| 2007 |
Cho DH, Tapscott SJ. Myotonic dystrophy: emerging mechanisms for DM1 and DM2. Biochimica Et Biophysica Acta. 1772: 195-204. PMID 16876389 DOI: 10.1016/j.bbadis.2006.05.013 |
0.16 |
|
| 2007 |
Tanaka H, Cao Y, Bergstrom DA, Kooperberg C, Tapscott SJ, Yao MC. Intrastrand annealing leads to the formation of a large DNA palindrome and determines the boundaries of genomic amplification in human cancer. Molecular and Cellular Biology. 27: 1993-2002. PMID 17242211 DOI: 10.1128/Mcb.01313-06 |
0.159 |
|
| 2010 |
Diede SJ, Guenthoer J, Geng LN, Mahoney SE, Marotta M, Olson JM, Tanaka H, Tapscott SJ. DNA methylation of developmental genes in pediatric medulloblastomas identified by denaturation analysis of methylation differences. Proceedings of the National Academy of Sciences of the United States of America. 107: 234-9. PMID 19966297 DOI: 10.1073/Pnas.0907606106 |
0.153 |
|
| 2014 |
Yao Z, Macquarrie KL, Fong AP, Tapscott SJ, Ruzzo WL, Gentleman RC. Discriminative motif analysis of high-throughput dataset. Bioinformatics (Oxford, England). 30: 775-83. PMID 24162561 DOI: 10.1093/Bioinformatics/Btt615 |
0.151 |
|
| 2008 |
Knight MA, Hernandez D, Diede SJ, Dauwerse HG, Rafferty I, van de Leemput J, Forrest SM, Gardner RJ, Storey E, van Ommen GJ, Tapscott SJ, Fischbeck KH, Singleton AB. A duplication at chromosome 11q12.2-11q12.3 is associated with spinocerebellar ataxia type 20. Human Molecular Genetics. 17: 3847-53. PMID 18801880 DOI: 10.1093/hmg/ddn283 |
0.148 |
|
| 2010 |
Rajapakse I, Scalzo D, Tapscott SJ, Kosak ST, Groudine M. Networking the nucleus. Molecular Systems Biology. 6: 395. PMID 20664641 DOI: 10.1038/Msb.2010.48 |
0.147 |
|
| 2017 |
Watanabe T, Marotta M, Suzuki R, Diede SJ, Tapscott SJ, Niida A, Chen X, Mouakkad L, Kondratova A, Giuliano AE, Orsulic S, Tanaka H. Impediment of Replication Forks by Long Non-coding RNA Provokes Chromosomal Rearrangements by Error-Prone Restart. Cell Reports. 21: 2223-2235. PMID 29166612 DOI: 10.1016/J.Celrep.2017.10.103 |
0.132 |
|
| 2015 |
Lemmers RJ, Goeman JJ, van der Vliet PJ, van Nieuwenhuizen MP, Balog J, Vos-Versteeg M, Camano P, Ramos Arroyo MA, Jerico I, Rogers MT, Miller DG, Upadhyaya M, Verschuuren JJ, Lopez de Munain Arregui A, van Engelen BG, ... ... Tapscott SJ, et al. Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2. Human Molecular Genetics. 24: 659-69. PMID 25256356 DOI: 10.1093/hmg/ddu486 |
0.127 |
|
| 2013 |
Diede SJ, Yao Z, Keyes CC, Tyler AE, Dey J, Hackett CS, Elsaesser K, Kemp CJ, Neiman PE, Weiss WA, Olson JM, Tapscott SJ. Fundamental differences in promoter CpG island DNA hypermethylation between human cancer and genetically engineered mouse models of cancer. Epigenetics : Official Journal of the Dna Methylation Society. 8: 1254-60. PMID 24107773 DOI: 10.4161/Epi.26486 |
0.122 |
|
| 2024 |
Arends T, Tsuchida H, Adeyemi RO, Tapscott SJ. DUX4-induced HSATII transcription causes KDM2A/B-PRC1 nuclear foci and impairs DNA damage response. The Journal of Cell Biology. 223. PMID 38451221 DOI: 10.1083/jcb.202303141 |
0.12 |
|
| 1981 |
Tapscott S. Pandemonium in Xanadu Romanticism Past and Present. 5: 23-40. DOI: 10.1080/08905498108583188 |
0.12 |
|
| 2005 |
Cho DH, Thienes CP, Mahoney SE, Analau E, Filippova GN, Tapscott SJ. Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. Molecular Cell. 20: 483-9. PMID 16285929 DOI: 10.1016/j.molcel.2005.09.002 |
0.12 |
|
| 2012 |
Guenthoer J, Diede SJ, Tanaka H, Chai X, Hsu L, Tapscott SJ, Porter PL. Assessment of palindromes as platforms for DNA amplification in breast cancer. Genome Research. 22: 232-45. PMID 21752925 DOI: 10.1101/Gr.117226.110 |
0.116 |
|
| 2018 |
Balog J, Goossens R, Lemmers RJLF, Straasheijm KR, van der Vliet PJ, Heuvel AVD, Cambieri C, Capet N, Feasson L, Manel V, Contet J, Kriek M, Donlin-Smith CM, Ruivenkamp CAL, Heard P, ... Tapscott SJ, et al. Monosomy 18p is a risk factor for facioscapulohumeral dystrophy. Journal of Medical Genetics. PMID 29563141 DOI: 10.1136/jmedgenet-2017-105153 |
0.102 |
|
| 2005 |
Lin CH, Hansen S, Wang Z, Storm DR, Tapscott SJ, Olson JM. The dosage of the neuroD2 transcription factor regulates amygdala development and emotional learning. Proceedings of the National Academy of Sciences of the United States of America. 102: 14877-82. PMID 16203979 DOI: 10.1073/Pnas.0506785102 |
0.101 |
|
| 2006 |
Lin CH, Tapscott SJ, Olson JM. Congenital hypothyroidism (cretinism) in neuroD2-deficient mice. Molecular and Cellular Biology. 26: 4311-5. PMID 16705180 DOI: 10.1128/Mcb.02158-05 |
0.099 |
|
| 2018 |
Mul K, Lemmers RJLF, Kriek M, van der Vliet PJ, van den Boogaard ML, Badrising UA, Graham JM, Lin AE, Brand H, Moore SA, Johnson K, Evangelista T, Töpf A, Straub V, Kapetanovic García S, ... ... Tapscott SJ, et al. FSHD type 2 and Bosma arhinia microphthalmia syndrome: Two faces of the same mutation. Neurology. PMID 29980640 DOI: 10.1212/Wnl.0000000000005958 |
0.095 |
|
| 2007 |
Jianchun D, Asawachaicharn A, Tapscott SJ, Parviz BA. Electronic detection of micro RNA Mir206 with molecularly-differentiated nanoelectrodes Proceedings of the 2nd Ieee International Conference On Nano/Micro Engineered and Molecular Systems, Ieee Nems 2007. 876-879. DOI: 10.1109/NEMS.2007.352157 |
0.091 |
|
| 2011 |
MacQuarrie KL, Tapscott SJ. Stuck in a balancing act: histone methyltransferase activity of KMT1A traps alveolar rhabdomyosarcomas in an undifferentiated state. Cell Cycle (Georgetown, Tex.). 10: 3225-6. PMID 21941084 DOI: 10.4161/cc.10.19.17451 |
0.084 |
|
| 1997 |
Tamimi RM, Steingrimsson E, Montgomery-Dyer K, Copeland NG, Jenkins NA, Tapscott SJ. NEUROD2 and NEUROD3 genes map to human chromosomes 17q12 and 5q23-q31 and mouse chromosomes 11 and 13, respectively Genomics. 40: 355-357. PMID 9119405 DOI: 10.1006/Geno.1996.4578 |
0.081 |
|
| 2015 |
Statland JM, Donlin-Smith CM, Tapscott SJ, Lemmers RJ, van der Maarel SM, Tawil R. Milder phenotype in facioscapulohumeral dystrophy with 7-10 residual D4Z4 repeats. Neurology. PMID 26561289 DOI: 10.1212/WNL.0000000000002217 |
0.074 |
|
| 2010 |
MacQuarrie KL, Yang J, Cao Y, Yao Z, Tapscott S. Rhabdomyosarcoma — A tumor balanced at a differentiation tipping point Developmental Biology. 344: 525. DOI: 10.1016/J.Ydbio.2010.05.482 |
0.071 |
|
| 2012 |
van der Maarel SM, Miller DG, Tawil R, Filippova GN, Tapscott SJ. Facioscapulohumeral muscular dystrophy: consequences of chromatin relaxation. Current Opinion in Neurology. 25: 614-20. PMID 22892954 DOI: 10.1097/WCO.0b013e328357f22d |
0.071 |
|
| 2013 |
Kerwin WS, Naumova A, Storb R, Tapscott SJ, Wang Z. Mapping contrast agent uptake and retention in MRI studies of myocardial perfusion: case control study of dogs with Duchenne muscular dystrophy. The International Journal of Cardiovascular Imaging. 29: 819-26. PMID 23070737 DOI: 10.1007/S10554-012-0137-Y |
0.063 |
|
| 2014 |
Statland J, Donlin-Smith CM, Tapscott SJ, van der Maarel SM, Tawil R. Multiplex Screen of Serum Biomarkers in Facioscapulohumeral Muscular Dystrophy. Journal of Neuromuscular Diseases. 1: 181-190. PMID 27858773 |
0.063 |
|
| 2014 |
Statland J, Donlin-Smith CM, Tapscott SJ, van der Maarel S, Tawil R. Multiplex Screen of Serum Biomarkers in Facioscapulohumeral Muscular Dystrophy. Journal of Neuromuscular Diseases. 1: 181-190. PMID 25705588 DOI: 10.3233/JND-140034 |
0.063 |
|
| 2011 |
Arnett AL, Garikipati D, Wang Z, Tapscott S, Chamberlain JS. Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector. Frontiers in Microbiology. 2: 220. PMID 22065964 DOI: 10.3389/Fmicb.2011.00220 |
0.059 |
|
| 2002 |
Timchenko LT, Tapscott SJ, Cooper TA, Monckton DG. Myotonic dystrophy: Discussion of molecular basis Advances in Experimental Medicine and Biology. 516: 27-45. PMID 12611434 DOI: 10.1007/978-1-4615-0117-6_2 |
0.054 |
|
| 2019 |
Yohe ME, Heske CM, Stewart E, Adamson PC, Ahmed N, Antonescu CR, Chen E, Collins N, Ehrlich A, Galindo RL, Gryder BE, Hahn H, Hammond S, Hatley ME, Hawkins DS, ... ... Tapscott SJ, et al. Insights into pediatric rhabdomyosarcoma research: Challenges and goals. Pediatric Blood & Cancer. e27869. PMID 31222885 DOI: 10.1002/Pbc.27869 |
0.05 |
|
| 2001 |
Cook DL, Farley JF, Tapscott SJ. A basis for a visual language for describing, archiving and analyzing functional models of complex biological systems. Genome Biology. 2: RESEARCH0012. PMID 11305940 |
0.044 |
|
| 2002 |
Tapscott SJ. Myotonic dystrophy, 3rd edition, by P. Harper, 436 pp., ill., London, W.B. Saunders, 2001, $85 Muscle & Nerve. 25: 926-926. DOI: 10.1002/mus.1238 |
0.043 |
|
| 1996 |
Tapscott SJ, Eskridge J, Kliot M. Surgical management of superficial siderosis following cervical nerve root avulsion Annals of Neurology. 40: 936-940. PMID 9007103 DOI: 10.1002/ana.410400620 |
0.04 |
|
| 1998 |
Friend SH, Tapscott SJ. Sibling rivalry, arrested development and chromosomal mayhem Nature Genetics. 19: 9-10. PMID 9590278 DOI: 10.1038/ng0598-9 |
0.035 |
|
| 2010 |
Diede SJ, Tanaka H, Bergstrom DA, Yao MC, Tapscott SJ. Genome-wide analysis of palindrome formation. Nature Genetics. 42: 279. PMID 20348960 DOI: 10.1038/ng0410-279 |
0.035 |
|
| 2013 |
Goldberg RW, Reeves G, Tapscott S, Medoff D, Dickerson F, Goldberg AP, Ryan AS, Fang LJ, Dixon LB. "MOVE!" Outcomes of a weight loss program modified for veterans with serious mental illness. Psychiatric Services (Washington, D.C.). 64: 737-44. PMID 23584716 DOI: 10.1176/appi.ps.201200314 |
0.03 |
|
| 2015 |
Tawil R, Padberg GW, Shaw DW, van der Maarel SM, Tapscott SJ. Clinical trial preparedness in facioscapulohumeral muscular dystrophy: Clinical, tissue, and imaging outcome measures 29-30 May 2015, Rochester, New York. Neuromuscular Disorders : Nmd. PMID 26627872 DOI: 10.1016/j.nmd.2015.10.005 |
0.03 |
|
| 2010 |
Rosenberg SD, Goldberg RW, Dixon LB, Wolford GL, Slade EP, Himelhoch S, Gallucci G, Potts W, Tapscott S, Welsh CJ. Assessing the STIRR model of best practices for blood-borne infections of clients with severe mental illness. Psychiatric Services (Washington, D.C.). 61: 885-91. PMID 20810586 DOI: 10.1176/ps.2010.61.9.885 |
0.03 |
|
| 2013 |
Slade EP, Rosenberg S, Dixon LB, Goldberg RW, Wolford GL, Himelhoch S, Tapscott S. Costs of a public health model to increase receipt of hepatitis-related services for persons with mental illness. Psychiatric Services (Washington, D.C.). 64: 127-33. PMID 23475451 DOI: 10.1176/appi.ps.000852011 |
0.024 |
|
| 2016 |
Kreyenbuhl J, Dixon LB, Brown CH, Medoff DR, Klingaman EA, Fang LJ, Tapscott S, Walsh MB. A Randomized Controlled Trial of a Patient-Centered Approach to Improve Screening for the Metabolic Side Effects of Antipsychotic Medications. Community Mental Health Journal. PMID 27061185 DOI: 10.1007/S10597-016-0007-5 |
0.023 |
|
| 2008 |
Tapscott S. Fidelity Opera News. 73. |
0.023 |
|
| 2012 |
Welsh C, Goldberg R, Tapscott S, Medoff D, Rosenberg S, Dixon L. "Shotgunning" in a population of patients with severe mental illness and comorbid substance use disorders. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 21: 120-5. PMID 22332854 DOI: 10.1111/j.1521-0391.2011.00201.x |
0.019 |
|
| 1978 |
Tapscott SJ. Leaves of Myself: Whitman's Egypt in "Song of Myself" American Literature. 50: 49. DOI: 10.2307/2925521 |
0.019 |
|
| 2014 |
Tawil R, Shaw DW, van der Maarel SM, Tapscott SJ. Clinical trial preparedness in facioscapulohumeral dystrophy: outcome measures and patient access: 8-9 April 2013, Leiden, The Netherlands. Neuromuscular Disorders : Nmd. 24: 79-85. PMID 24011701 DOI: 10.1016/j.nmd.2013.07.009 |
0.018 |
|
| 2015 |
Klingaman EA, Medoff DR, Park SG, Brown CH, Fang L, Dixon LB, Hack SM, Tapscott SL, Walsh MB, Kreyenbuhl JA. Consumer Satisfaction With Psychiatric Services: The Role of Shared Decision Making and the Therapeutic Relationship. Psychiatric Rehabilitation Journal. PMID 25664755 DOI: 10.1037/Prj0000114 |
0.018 |
|
| 2007 |
Brand RJ, Tapscott S. Acoustic packaging of action sequences by infants Infancy. 11: 321-332. DOI: 10.1111/J.1532-7078.2007.Tb00230.X |
0.018 |
|
| 1978 |
Tapscott SJ. Williams's Paterson: Doctor and Democrat The Yearbook of English Studies. 8: 77. DOI: 10.2307/3506766 |
0.017 |
|
| 2009 |
Goldberg RW, Tapscott SL, Calmes CA, Wolfe RS. HIV and hepatitis C knowledge among individuals with serious mental illness. Psychiatric Rehabilitation Journal. 33: 47-9. PMID 19592379 DOI: 10.2975/33.1.2009.47.49 |
0.015 |
|
| 1985 |
Steinman LM, Hoffman D, Loevy SR, Williams WC, Rapp C, Sayre HM, Tapscott S. William Carlos Williams's Dreams of Things Contemporary Literature. 26: 497. DOI: 10.2307/1208121 |
0.015 |
|
| 2001 |
Tapscott SJ, Thornton CA. Biomedicine: Reconstructing myotonic dystrophy Science. 293: 816-817. PMID 11486078 DOI: 10.1126/science.1063517 |
0.014 |
|
| 1981 |
Tapscott S. In the Darkness of the Body The Missouri Review. 4: 12-13. DOI: 10.1353/mis.1981.0068 |
0.013 |
|
| 1987 |
Quackenbush LH, Neruda P, Tapscott SJ. 100 Love Sonnets (Cien sonetos de amor) Hispania. 70: 513. DOI: 10.2307/343420 |
0.012 |
|
| 2016 |
Tapscott S. Day Unto Day by Martha Collins Pleiades: Literature in Context. 36: 61-63. DOI: 10.1353/plc.2016.0054 |
0.01 |
|
| 2009 |
Kemnitz JW, Schultz-Darken N, Tapscott SJ. An IACUC perspective on animal models of sleep-disordered breathing. Ilar Journal / National Research Council, Institute of Laboratory Animal Resources. 50: 312-3. PMID 19506317 DOI: 10.1093/Ilar.50.3.312 |
0.01 |
|
| 2005 |
Yonemitsu Y, Yamano T, Udono H, Tanaka H, Bergstrom DA, Yao M, Tapscott SJ, Mori M. Abstract of Symposium Human Cell. 18: 29-33. DOI: 10.1007/Bf03214525 |
0.01 |
|
| 2003 |
Gies M, Mistral G, Tapscott S, Fiol-Matta L. Rediscovering Gabriela Mistral The Women's Review of Books. 20: 14. DOI: 10.2307/4024139 |
0.01 |
|
| 1983 |
Tapscott S. When the Water Broke The Missouri Review. 6: 24-25. DOI: 10.1353/mis.1983.0002 |
0.01 |
|
| 1981 |
Tapscott S. Whitman in Paterson American Literature. 53: 291. DOI: 10.2307/2926106 |
0.01 |
|
| 1981 |
Tapscott S. Because She is Pregnant and Full of Her California The Missouri Review. 4: 15-15. DOI: 10.1353/mis.1981.0044 |
0.01 |
|
| 1981 |
Tapscott S. In the Darkness of the Body, and: Irises, and: Because She is Pregnant and Full of Her California The Missouri Review. 4: 12-15. DOI: 10.1353/mis.1981.0018 |
0.01 |
|
| Hide low-probability matches. |